NeuropharmacologyHumansPsilocybinDouble-Blind MethodMaleHallucinogens
Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.
Luisa Prochazkova, Josephine Marschall, Dominique Patrick Lippelt, Neil R Schon, Martin Kuchař, Bernhard Hommel
Published: 202610.1016/j.neuropharm.2025.110722
Abstract
OBJECTIVE: Microdosing psychedelics has been widely reported to enhance focus and problem-solving, sparking interest in its potential to treat attentional disorders such as ADHD. However, existing studies largely rely on anecdotal evidence and lack a…
Preview only. Read the full abstract at the source